China’s CanSino transfers technology to Malaysian firm to process Covid-19 vaccine

Published on 10 Sep 2021 12:07:36 PM

China’s CanSino Biologics has helped Malaysia cross another milestone in vaccine manufacturing, this time by transferring technology to enable the making of the local "fill and finish" CanSino Covid-19 vaccine based on the adenovirus platform.

WATCH MORE: https://thestartv.com/c/news
SUBSCRIBE: https://cutt.ly/TheStar
LIKE: https://fb.com/TheStarOnline